Catalog No.
Product Name
Application
Product Information
Citations
-
Antibiotic
A 53868A is an antibiotic derived from Streptomyces luridus, specifically targeting bacterial cell wall synthesis. This compound exhibits potent antimicrobial activity, making it suitable for research applications in microbiology, drug resistance studies, and the exploration of new therapeutic agents against bacterial infections. -
Alkaloid Antibiotic
Hatomamicin is an alkaloid antibiotic with potent activity against Gram-positive bacteria. Isolated from the culture filtrate of Sucrose Polyspora, it serves as a valuable tool in antibacterial research. Its mechanism of action and biological activity make it relevant for studies focused on developing new antimicrobial therapies. -
Antibiotic
Deflectin 1a is an antibiotic that primarily targets bacterial cells, demonstrating the ability to lyse both bacteria and red blood cells. Additionally, it exhibits inhibitory effects on Ehrlich ascites cancer cells, making it a valuable tool in cancer research. Notably, its activity can be modulated by the presence of serum or serum albumin, providing insights into its mechanism and potential applications in various biological studies. -
Antineoplastic Antibiotic
Nortopixantrone dihydrochloride is a 9-aza-anthrapyrazole-based antineoplastic antibiotic that targets cancer cell proliferation. It exhibits significant cytotoxic activity against a variety of tumor cell lines, making it a valuable tool in cancer research. This compound is utilized in studies aimed at understanding its mechanisms of action and potential therapeutic applications in oncology. -
Antibiotic
Demethylolivomycin B is an antitumor antibiotic that primarily targets bacterial and cancerous cells. It exhibits modest activity against Gram-positive bacteria and demonstrates potential therapeutic effects in tumor models. This compound is relevant for research focused on antibiotic resistance and cancer treatment strategies. -
Antibiotic
Mureidomycin B is an antibiotic that targets Pseudomonas aeruginosa, exhibiting potent antibacterial activity against this pathogen. It is primarily utilized in research related to bacterial infections and the development of antibiotic resistance. This compound can serve as a valuable tool in exploring therapeutic options for infections caused by multidrug-resistant strains. -
Antitumor Antibiotic
Bis(N-methylthioformohydroxamate)nickel (II) acts as an antitumor antibiotic, leveraging the properties of metallic nickel. This compound exhibits significant antimicrobial activity against both Gram-positive and Gram-negative bacteria while demonstrating potent antitumor effects. It is valuable for research in oncology and microbiology, providing insights into therapeutic applications and mechanisms of action against resistant pathogens. -
Bacterial Inhibitor
Altromycin F is an anthraquinone-derived antibiotic that functions as a bacterial inhibitor by targeting and disrupting bacterial cell function. This compound exhibits significant antibacterial activity specifically against Gram-positive bacteria, including Streptococcus and Staphylococcus, with a microbial inhibitory concentration (MIC) ranging from 0.2 to 3.12 μg/mL. Altromycin F is valuable for research applications focused on understanding bacterial resistance and developing new antibacterial strategies. -
Antibiotic
Pyralomicin 1d is an antibiotic that exhibits potent antibacterial activity by targeting bacterial ribosomes, thereby inhibiting protein synthesis. This compound is valuable for research applications focused on understanding bacterial resistance mechanisms and developing new antimicrobial therapies. Its efficacy against various Gram-positive and Gram-negative bacteria makes it a pertinent tool in microbiological studies and antibiotic development. -
Antibiotic
Griseorhodin A is a quinone antibiotic that primarily targets Gram-positive bacteria. This compound exhibits significant antibacterial activity, making it valuable for research focusing on bacterial infections and resistance mechanisms. Its distinctive mechanism of action contributes to the exploration of novel therapeutic strategies against resistant bacterial strains. -
Antitumor Antibiotic
Resorthiomycin is an antitumor antibiotic known for its ability to inhibit leukemia cell lines, specifically L5178Y, in vitro. This compound demonstrates significant cytotoxic activity, making it a valuable tool in cancer research. Its mechanisms of action offer insights into the potential therapeutic applications in combating hematological malignancies. -
Antibiotic
Pyrazomycin II, an antibiotic, functions as a competitive inhibitor of pyrimidine nucleoside metabolism. Its primary biological activity demonstrates efficacy against various bacterial strains, making it a valuable tool in antibiotic research. Pyrazomycin II can be utilized in studies focused on antibacterial mechanisms and the development of new therapeutic strategies for bacterial infections. -
Antibiotic
Polymyxin M is a cyclic peptide antibiotic that targets the outer membrane of Gram-negative bacteria. It disrupts bacterial cell membrane integrity, leading to cell lysis and death. Polymyxin M is primarily utilized in research focusing on antibiotic resistance and the mechanisms of bacterial infection. Its effectiveness against multidrug-resistant pathogens makes it a valuable tool for studies in microbiology and infectious disease. -
Antibiotic
Maridomycin VI is a macrolide antibiotic that primarily targets Gram-positive bacteria and mycoplasma. It demonstrates significant antibacterial activity and has been shown to provide protective effects in murine models of Gram-positive bacterial infections. This compound is potentially useful for research applications focused on bacterial resistance and antibiotic efficacy. -
Antibiotic
Mirosamicin is a potent antibiotic that exhibits significant antibacterial activity against a broad spectrum of gram-positive bacteria, select gram-negative bacteria, and mycoplasma. Its efficacy makes it a valuable reagent for research in food safety monitoring and microbial resistance studies. -
Bacterial Inhibitor
Cefoselis hydrochloride is a fourth-generation cephalosporin and a β-lactam antibiotic that targets bacterial cell wall synthesis. It demonstrates potent antibacterial activity against a broad spectrum of both Gram-positive and Gram-negative bacteria. Furthermore, cefoselis hydrochloride effectively penetrates the blood-brain barrier, making it a valuable compound for research applications in infectious diseases and central nervous system infections. -
Antibiotic
Dihydrotetrodecamycin is an antibiotic produced by the fermentation of Streptomyces nashvillensis MJ885-mF8. This compound exhibits significant antimicrobial activity, with minimum inhibitory concentration (MIC) values of 50 mg/mL against both Pasteurella piscicida sp. 639 and P. piscicida sp. 6356. It serves as a valuable tool for research into antibiotic resistance and the development of novel therapeutic agents. -
Antibiotic
Pyrisulfoxin A is an antibiotic derived from the bacterium Streptomyces callfornicus BS-75. This compound exhibits significant antibacterial properties, making it a valuable reagent for research focused on microbial resistance and antibiotic efficacy. Pyrisulfoxin A serves as a tool for investigating the mechanisms of bacterial inhibition and evaluating new therapeutic approaches in infectious diseases. -
Antitumor Antibiotic
Anguinomycin B is an antitumor antibiotic that targets cancer cells through its potent cytotoxic activity. It has been shown to exhibit significant efficacy against murine P388 leukemia cells, making it a valuable reagent for cancer research and drug development applications. Its unique mechanism of action and ability to induce apoptosis in tumor cells underscore its potential for further investigation in the field of oncology. -
Antibiotic
Monamycin D2 is an ester peptide antibiotic that primarily targets Gram-positive bacteria. It exhibits potent antibacterial activity, making it a valuable tool for research in microbiology and antibiotic resistance studies. Its unique mechanism of action presents opportunities for further exploration in developing therapeutic agents against bacterial infections. -
Antibiotic
Kikumycin A is an antibiotic derived from the bacterium Streptomyces. It demonstrates significant antibacterial activity against both Gram-positive and Gram-negative bacteria, making it a versatile agent in microbiological research. Additionally, Kikumycin A possesses antitrichomonal properties, with a minimum inhibitory concentration (MIC) of 25 μg/mL against Trichomonas foetus. Its broad-spectrum efficacy supports its utility in studies focused on bacterial and protozoan infections. -
Antibiotic
Ferrimycin A1 is an iron-containing peptide antibiotic that functions as a competitive antagonist and microbial growth factor. This compound exhibits potent antibacterial activity, making it valuable for research focused on microbial inhibition and the development of new antibiotic therapies. Its unique properties facilitate studies in microbial growth regulation and antibiotic resistance mechanisms. -
Antibiotic Adjuvant
Antibiotic Adjuvant 4 is an effective efflux pump inhibitor that enhances the efficacy of antibiotics. It significantly downregulates virulence-related genes in Staphylococcus aureus, making it a valuable tool for research on antibiotic resistance. This compound can be utilized in combination with antibiotics, such as Ciprofloxacin, to improve their effectiveness against multi-drug resistant strains of Staphylococcus aureus. Its role in modulating bacterial responses highlights its potential application in antibiotic adjuvant research. -
Antibiotic
Halomicin D is an ansamycin antibiotic that exhibits broad-spectrum activity against both Gram-positive and Gram-negative bacteria. It functions by inhibiting crucial bacterial processes, making it a valuable reagent for research applications in microbiology and antibiotic resistance studies. Its antibacterial properties are essential for investigating mechanisms of action and developing new therapeutic strategies. -
Antibiotic
Flavipucine is a glutarimide antibiotic derived from the strain of Aspergillus flavipes F-2090/7. It exhibits significant antibacterial activity against Bacillus subtilis and demonstrates antiprotozoal properties. Additionally, Flavipucine showcases cytotoxic effects against various cancer cell lines, making it a valuable agent for research applications in microbiology and cancer studies. -
Antitumor Antibiotic
Hitachimycin is a macrolide antibiotic known for its ability to inhibit tumor cell growth, showcasing significant antitumor activity. It also exhibits antiprotozoal effects, making it relevant for research in cancer therapy and protozoal infections. This compound can be utilized in various biomedical studies aimed at understanding tumorigenesis and potential treatment pathways. -
Antibiotic
Cefazedone sodium is a first-generation cephalosporin antibiotic targeting bacterial cell wall synthesis. It exhibits broad-spectrum antibacterial activity against both Gram-positive and Gram-negative bacteria. This compound is widely used in microbiological research to study bacterial resistance mechanisms and is essential for the development of new antimicrobial therapies. -
Antibiotic
Polymyxin D2 is an antibiotic derived from Bacillus polymyxa, demonstrating significant antibacterial activity. Its structure features a cyclic heptapeptide core and a tripeptide side chain with a fatty acyl group, contributing to its potent effects. This compound is valuable for research in anti-infective applications, providing insights into bacterial resistance mechanisms and therapeutic interventions. -
Antibiotic
Napsamycin C is an antibiotic that specifically targets Pseudomonas aeruginosa, exhibiting significant antibacterial activity against this organism and related Pseudomonas species. Its efficacy is notably reduced against other Gram-positive and Gram-negative bacteria, making it a valuable reagent for research focused on combating Pseudomonas infections. This compound is useful in studies of bacterial resistance and antibiotic efficacy. -
Antibiotic
Asparenomycin C is a carbapenem antibiotic that exhibits potent β-lactamase inhibition. This compound demonstrates significant antibacterial activity against a range of Gram-positive and Gram-negative bacteria, making it a valuable tool in studying antibiotic resistance mechanisms. It is utilized in research applications aimed at developing new antibiotics and understanding the interactions between β-lactam antibiotics and bacterial enzymes. -
Antibiotic
Altromycin B is an antibiotic that belongs to the pluramycin family, derived from South African bush soil. It exhibits selective antibacterial activity against Gram-positive bacteria and demonstrates in vivo efficacy against various cancers, including P388 leukemia, colon cancer, lung cancer, and ovarian cancer. This compound is valuable for research in antimicrobial resistance and cancer treatment studies. -
Antibiotic
Saquayamycin D is an antibiotic derived from the culture broth of Streptomyces nodosus. This compound demonstrates significant antibacterial activity against a range of gram-positive bacteria, exhibiting a minimum inhibitory concentration (MIC) of 12.5-50 μg/mL. Additionally, Saquayamycin D effectively inhibits the proliferation of both Doxorubicin-sensitive P388/S and Doxorubicin-resistant P388/ADR cell lines, with an IC50 of 0.15 μg/mL, making it valuable for cancer research applications. -
Antibiotic
Flambamycin is an antibiotic derived from the Streptomyces hygroscopicus DS 23230 strain, exhibiting activity against both Gram-positive and Gram-negative cocci, as well as certain Gram-positive rods. Its antimicrobial properties make it a valuable tool for research focused on antibiotic screening and the evaluation of novel antibacterial agents. -
Antitumor Antibiotic
Gilvusmycin is an antitumor antibiotic that exhibits potent cytotoxic activity against various cancer cell lines. It effectively inhibits P388, K562, A431, and MKN28 cells, demonstrating IC50 values of 0.08, 0.86, 0.72, and 0.75 ng/mL, respectively. This compound is valuable for research applications in cancer biology and the development of novel anticancer therapies. -
Antibiotic
Mycoplanecin B is a cyclic peptide antibiotic known for its potent antibacterial activity. It selectively targets bacterial cell wall synthesis, inhibiting growth and proliferation of susceptible pathogens. This compound is primarily utilized in research applications focused on antimicrobial resistance and the development of novel antibiotic therapies. -
Antibacterial Agent
O-Demethylpaulomycin A is an antibiotic that exhibits potent antibacterial activity, specifically targeting Gram-positive bacteria. This compound is particularly effective against Staphylococcus aureus, making it a valuable reagent for research applications focused on bacterial infections and antibiotic resistance. Its mechanism of action may provide insights into new therapeutic strategies for combating resistant bacterial strains. -
Antibiotic
Asparenomycin B is a carbapenem antibiotic that acts by inhibiting β-lactamase enzymes, thereby enhancing its efficacy against resistant bacterial strains. This compound exhibits robust antibacterial activity and is valuable for research applications focused on drug resistance mechanisms and antibiotic development. Its unique properties make it a significant tool for studies in microbiology and pharmacology. -
Antibiotic
Milbemycin α12 is an antibiotic that exerts its effects by targeting and disrupting the nervous systems of nematodes and mites. It is primarily utilized in research focused on parasitic infections and pest control. This compound demonstrates potent anthelmintic and acaricidal properties, making it valuable for studies related to parasitology and agricultural applications. -
Antibiotic
Oudenone is an oxygen-containing heterocyclic antibiotic that exhibits weak antibacterial and antifungal activities. It is also noted for its antihypertensive effects, demonstrating efficacy in reducing blood pressure in spontaneous hypertension models in rats via both intraperitoneal injection and oral administration. This compound may serve as a valuable tool in research focusing on antibiotic efficacy and hypertension management. -
Antibiotic
Cefpimizole is a broad-spectrum cephalosporin antibiotic that targets bacterial cell wall synthesis. It effectively inhibits a variety of ampicillin-resistant bacteria and demonstrates activity against gram-negative species. Additionally, Cefpimizole enhances the phagocytic activity of macrophages and neutrophils, making it valuable for studies in antimicrobial resistance and immune response modulation. -
Penicillin Antibiotic
Pivampicillin hydrochloride is a penicillin antibiotic that acts as a prodrug for Ampicillin. This compound exhibits broad-spectrum antibacterial activity by targeting bacterial cell wall synthesis. It is utilized in research to investigate the mechanisms of antibiotic resistance and in the development of novel antibacterial therapies. -
Antibiotic
Methyl-6-gingerol is an antimicrobial compound primarily targeting bacterial efflux mechanisms. Isolated from Aframomum melegueta, it demonstrates significant anti-mycobacterial activity by inhibiting the efflux of toxins in Mycobacterium species. This property makes it a valuable reagent for research in antibiotic development and the study of mycobacterial resistance mechanisms. -
Antibiotic
Tiacumicin C is an antibiotic that effectively targets Gram-positive bacteria. It exhibits strong antibacterial properties, making it a valuable tool in research focused on bacterial infections and resistance mechanisms. Its unique structure and mechanism of action assist in the exploration of therapeutic strategies against resistant bacterial strains. -
Antibacterial Agent
Sulopenem sodium is a parenteral penem antibiotic that exhibits broad-spectrum antibacterial activity against both Gram-positive and Gram-negative bacteria. This compound is particularly relevant for the treatment of urinary tract infections and intra-abdominal infections, offering a therapeutic option in complex infectious diseases. However, it is ineffective against Pseudomonas aeruginosa and Xanthomonas maltophilia. -
Antibiotic
Monamycin I is an ester peptide antibiotic known for its efficacy against Gram-positive bacteria. Its mechanism involves disrupting bacterial cell wall synthesis, thereby inhibiting growth. This compound is valuable for research into antibiotic resistance and the development of new antibacterial agents. Monamycin I provides a useful tool for studies focused on bacterial infection mechanisms and the evaluation of antibiotic susceptibility. -
Antibacterial Agent
(Rac)-LY193239 is a racemic variant of LY193239, a higher-lactam pyrazolidinone with potent antibacterial properties. This compound demonstrates significant antimicrobial activity, making it a valuable tool for research into bacterial infections. Its mechanism as an antibacterial agent allows for investigations into therapeutic applications and the development of new antibiotics. -
Antibiotic
Mimosamycin is an antibiotic that exerts its activity primarily against mycobacteria and resistant strains of Streptomyces. Its mechanism of action involves inhibiting the growth of these microorganisms, making it a valuable reagent for research on antibiotic resistance and mycobacterial infections. This compound is essential for studies aiming to develop new therapeutic strategies and understand the underlying biology of resistant bacterial strains. -
Antibiotic
Roridin H is an antibiotic that targets bacterial ribosomes, inhibiting protein synthesis. Isolated from the fungus Myrothecium verrucaria, it exhibits significant antimicrobial activity against various pathogens. This compound is primarily utilized in research applications focusing on antibiotic resistance and microbial biochemistry. -
Antibiotic
Pyralomicin 1c is an antibiotic that exerts its antibacterial activity by targeting bacterial protein synthesis. It has demonstrated effectiveness against a range of Gram-positive bacteria, making it a valuable compound for the study of antibiotic mechanisms and resistance. Researchers can utilize Pyralomicin 1c in investigations aimed at developing new antimicrobial therapies and understanding bacterial pathogenesis. -
Antibiotic
Actithiazic acid is a nitrogen- and sulfur-containing antibiotic that exerts its effects primarily by targeting mycobacteria. This compound demonstrates significant antibacterial activity, making it useful for research focused on mycobacterial infections. Its mechanism of action and efficacy in combating resistant strains position it as a valuable reagent for the study of antibiotic resistance and potential therapeutic developments in infectious diseases.
